SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-059322
Filing Date
2021-11-15
Accepted
2021-11-15 16:02:29
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_cmlifesciences3.htm   iXBRL 10-Q 452347
2 CERTIFICATION f10q0921ex31-1_cmlife3.htm EX-31.1 11445
3 CERTIFICATION f10q0921ex31-2_cmlife3.htm EX-31.2 11324
4 CERTIFICATION f10q0921ex32-1_cmlife3.htm EX-32.1 4570
5 CERTIFICATION f10q0921ex32-2_cmlife3.htm EX-32.2 4569
  Complete submission text file 0001213900-21-059322.txt   3244010

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cmlt-20210930.xsd EX-101.SCH 45712
7 XBRL CALCULATION FILE cmlt-20210930_cal.xml EX-101.CAL 22637
8 XBRL DEFINITION FILE cmlt-20210930_def.xml EX-101.DEF 204809
9 XBRL LABEL FILE cmlt-20210930_lab.xml EX-101.LAB 345600
10 XBRL PRESENTATION FILE cmlt-20210930_pre.xml EX-101.PRE 207641
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_cmlifesciences3_htm.xml XML 295920
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40312 | Film No.: 211410162
SIC: 2834 Pharmaceutical Preparations